product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
VISTA (D1L2G™) XP Rabbit mAb
catalog :
64953
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D1L2G™
reactivity :
human, mouse
application :
immunohistochemistry, immunohistochemistry - paraffin section
citations: 6
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1d
Chen Y, Feng R, He B, Wang J, Xian N, Huang G, et al. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Front Mol Biosci. 2021;8:777370 pubmed publisher
  • immunohistochemistry; mouse; 1:200; fig 1a
Borggrewe M, Kooistra S, Wesseling E, Gierschek F, Brummer M, Nowak E, et al. VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology. Acta Neuropathol Commun. 2021;9:91 pubmed publisher
Hu L, Chen L, Xiao Z, Zheng X, Chen Y, Xian N, et al. Ablation of T cell-associated PD-1H enhances functionality and promotes adoptive immunotherapy. JCI Insight. 2021;: pubmed publisher
Dufva O, Pölönen P, Brück O, Keränen M, Klievink J, Mehtonen J, et al. Immunogenomic Landscape of Hematological Malignancies. Cancer Cell. 2020;: pubmed publisher
Zhang M, Pang H, Zhao W, Li Y, Yan L, Dong Z, et al. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma. BMC Cancer. 2018;18:511 pubmed publisher
Ceeraz S, Eszterhas S, Sergent P, Armstrong D, Ashare A, BROUGHTON T, et al. VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes. Arthritis Res Ther. 2017;19:270 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.